Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease

ACS Chemical Neuroscience

Volumn 7, Issue 1, 2016, Pages 34-39

  Horvath, Istvan ^a   Jia, Xueen ^a   Johansson, Per ^b,c   Wang, Chao ^a   Moskalenko, Roman ^a,d   Steinau, Andreas ^a   Forsgren, Lars ^a   Wågberg, Thomas ^a   Svensson, Johan ^c,e   Zetterberg, Henrik ^c,f   Morozova Roche, Ludmilla A ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Department of Neuropsychiatry Skaraborg Central Hospital   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d SUMY STATE UNIVERSITY   (Ukraine)

^e CENTRAL HOSPITAL   (Sweden)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; amyloid; A 1 42; biomarkers; cerebrospinal fluid; inflammation; mild cognitive impairment; S100A9

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALGRANULIN B; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOTTING; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; COGNITION DISORDERS; COMPLICATION; PSYCHIATRIC EMERGENCY SERVICE; STATISTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOMARKERS; CALGRANULIN B; COGNITION DISORDERS; DISEASE PROGRESSION; EMERGENCY SERVICES, PSYCHIATRIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; PEPTIDE FRAGMENTS; STATISTICS AS TOPIC; TAU PROTEINS;

EID: 84955622549     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/acschemneuro.5b00265     Document Type: Article

References (23)

1. Blennow, K., Mattsson, N., Scholl, M., Hansson, O., and Zetterberg, H. (2015) Amyloid biomarkers in Alzheimer's disease Trends Pharmacol. Sci. 36, 297-309 10.1016/j.tips.2015.03.002
2. Blennow, K. and Hampel, H. (2003) CSF markers for incipient Alzheimer's disease Lancet Neurol. 2, 605-613 10.1016/S1474-4422(03)00530-1
3. Johansson, P., Mattsson, N., Hansson, O., Wallin, A., Johansson, J. O., Andreasson, U., Zetterberg, H., Blennow, K., and Svensson, J. (2011) Cerebrospinal fluid biomarkers for Alzheimer's disease: diagnostic performance in a homogeneous mono-center population J. Alzheimer's Dis. 24, 537-546 10.3233/JAD-2011-101878
4. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., and Ashe, K. H. (2006) A specific amyloid-beta protein assembly in the brain impairs memory Nature 440, 352-357 10.1038/nature04533
5. Selkoe, D. J. (1991) The molecular pathology of Alzheimer's disease Neuron 6, 487-498 10.1016/0896-6273(91)90052-2
6. Kapetanovic, R., Bokil, N. J., and Sweet, M. J. (2015) Innate immune perturbations, accumulating DAMPs and inflammasome dysregulation: A ticking time bomb in ageing Ageing Res. Rev. 10.1016/j.arr.2015.02.005
7. McGeer, E. G. and McGeer, P. L. (2010) Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy J. Alzheimer's Dis. 19, 355-361 10.3233/JAD-2010-1219
8. Ha, T. Y., Chang, K. A., Kim, J., Kim, H. S., Kim, S., Chong, Y. H., and Suh, Y. H. (2010) S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model PLoS One 5, e8840 10.1371/journal.pone.0008840
9. Swindell, W. R., Johnston, A., Xing, X., Little, A., Robichaud, P., Voorhees, J. J., Fisher, G., and Gudjonsson, J. E. (2013) Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation Sci. Rep. 3, 1215 10.1038/srep01215
10. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., George-Hyslop, P., St, Singleton, A., and Hardy, J. (2013) TREM2 variants in Alzheimer's disease N. Engl. J. Med. 368, 117-127 10.1056/NEJMoa1211851
11. Cole, G. M. and Frautschy, S. A. (2010) Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease CNS Neurol. Disord.: Drug Targets 9, 140-148 10.2174/187152710791011991
12. in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M., and Stricker, B. H. (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease N. Engl. J. Med. 345, 1515-1521 10.1056/NEJMoa010178
13. Shepherd, C. E., Goyette, J., Utter, V., Rahimi, F., Yang, Z., Geczy, C. L., and Halliday, G. M. (2006) Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease Neurobiol. Aging 27, 1554-1563 10.1016/j.neurobiolaging.2005.09.033
14. Wang, C., Klechikov, A. G., Gharibyan, A. L., Warmlander, S. K., Jarvet, J., Zhao, L., Jia, X., Shankar, S. K., Olofsson, A., Brannstrom, T., Mu, Y., Graslund, A., and Morozova-Roche, L. A. (2014) The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade Acta Neuropathol. 127, 507-522 10.1007/s00401-013-1208-4
15. Wache, C., Klein, M., Ostergaard, C., Angele, B., Hacker, H., Pfister, H. W., Pruenster, M., Sperandio, M., Leanderson, T., Roth, J., Vogl, T., and Koedel, U. (2015) Myeloid-related protein 14 promotes inflammation and injury in meningitis J. Infect. Dis. 212, 247-257 10.1093/infdis/jiv028
16. Kummer, M. P., Vogl, T., Axt, D., Griep, A., Vieira-Saecker, A., Jessen, F., Gelpi, E., Roth, J., and Heneka, M. T. (2012) Mrp14 deficiency ameliorates amyloid beta burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing J. Neurosci. 32, 17824-17829 10.1523/JNEUROSCI.1504-12.2012
17. Castillo-Carranza, D. L., Guerrero-Munoz, M. J., Sengupta, U., Hernandez, C., Barrett, A. D., Dineley, K., and Kayed, R. (2015) Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model J. Neurosci. 35, 4857-4868 10.1523/JNEUROSCI.4989-14.2015
18. Bloom, G. S. (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer's disease pathogenesis JAMA Neurol. 71, 505-508 10.1001/jamaneurol.2013.5847
19. Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M. O., Jicha, G. A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L. C., Vellas, B., Visser, P. J., Schneider, L., Stern, Y., Scheltens, P., and Cummings, J. L. (2014) Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria Lancet Neurol. 13, 614-629 10.1016/S1474-4422(14)70090-0
20. Blennow, K. and Zetterberg, H. (2015) The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events Front. Neurosci. 9, 345 10.3389/fnins.2015.00345
21. Dubois, B., Feldman, H. H., Jacova, C., Dekosky, S. T., Barberger-Gateau, P., Cummings, J., Delocourte, A., Galasko, D., Gauthier, S., Jicha, G., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Solloway, S., Stern, Y., Visser, P. J., and Scheltens, P. (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol. 6, 734-746 10.1016/S1474-4422(07)70178-3
22. Folstein, M. F., Folstein, S. E., and McHugh, P. R. (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12, 189-198 10.1016/0022-3956(75)90026-6
23. Almeida, R. P., Schultz, S. A., Austin, B. P., Boots, E. A., Dowling, N. M., Gleason, C. E., Bendlin, B. B., Sager, M. A., Hermann, B. P., Zetterberg, H., Carlsson, C. M., Johnson, S. C., Asthana, S., and Okonkwo, O. C. (2015) Effect of cognitive reserve on age-related changes in cerebrospinal fluid biomarkers of Alzheimer's disease JAMA Neurol. 72, 699-706 10.1001/jamaneurol.2015.0098